ADMA Biologics Inc (NASDAQ:ADMA)

7.81
Delayed Data
As of 3:02pm ET
 -0.405 / -4.93%
Today’s Change
7.00
Today|||52-Week Range
14.00
-30.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues761.0K1.1M3.1M5.9M
 
 
 
 
 
Cost of Goods Sold1.8M487.0K4.2M7.3M
 
 
 
 
 
Depreciation And Amortization219.6K182.1K210.6K247.9K
 
 
 
 
 
 
Operating ExpensesGross Income-1.3M449.1K-1.4M-1.7M
 
 
 
 
 
General Expenses1.4M8.4M13.7M14.3M
 
 
 
 
 
Research And Development0.003.5M9.3M9.5M
 
 
 
 
Total Operating Expenses3.4M9.0M18.1M21.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.7M-7.9M-15.0M-16.0M
 
 
 
 
 
Extraordinary Credit--0.0043.3K0.00
 
 
Extraordinary Charge--0.000.00-74.4K
 
 
Interest Expense On Debt1.6M30.7K618.2K1.3M
 
 
 
 
 
Other Expenses-1.9M0.0082.5K0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.2M-7.9M-15.5M-17.4M
 
 
 
 
 
Income Taxes-320.8K-617.6K0.00-551.7K
 
 
 
 
Net Income-5.9M-7.3M-15.5M-16.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS353.1K4.1M6.5M9.3M
 
 
 
 
 
Shares To Calculate EPS Diluted353.1K4.1M6.5M9.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$16.72-$1.76-$2.38-$1.81
 
 
 
 
 
EPS Diluted-$16.72-$1.76-$2.38-$1.81
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account